BACKGROUND The Victorian Government Department of Health funded a diphtheria, tetanus and acellular pertussis vaccine for parents of infants from June 2009 to June 2012 as part of a cocooning strategy for the control of pertussis. The aim of this study was to assess parents' attitudes and awareness of the vaccination program, and to estimate vaccine uptake. METHODS A cross-sectional survey of...

I nfection with Bordetella pertussis, the cause of whooping cough, is common in the adult and adolescent population because immunity from prior illness or childhood vaccination is not lifelong. As many as 800,000 to 3.3 million cases of pertussis may occur annually in the United States. Because pertussis causes cough for prolonged periods of time, and the organism spreads readily from person to...

BACKGROUND Pertussis is the only vaccine-preventable disease that has re-emerged in Israel. The reported crude incidence of the disease increased 16-fold since 1998. OBJECTIVES To describe the epidemiology of pertussis and explain the substantial increase in reported pertussis incidence in Israel in recent years. METHODS Crude and specific pertussis incidence by age, patient immunization st...

Pertussis is a vaccine-preventable childhood disease characterized by bouts of "whooping cough." In 2006, vaccination guidelines for pertussis were recommended to include Tdap for routine use in adolescents 11 to 18 years of age and single doses for adults 19 to 64 years of age. Despite these revisions in the vaccination guidelines for adolescents, the incidence of the disease continues to incr...

A subanalysis of a recent cohort efficacy trial of a pertussis vaccine was performed to determine its efficacy against cough illnesses due to Bordetella parapertussis infections. Infants received four doses of either the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis (DTaP) vaccine or the Lederle whole-cell component diphtheria and tetanus toxoids and ...

AbstractBackground The Cambodia pertussis immunization schedule includes three doses given at age 6, 10 and 14 weeks using a whole-pertussis vaccine. No booster are included. Pertussis biological diagnosis is unavailable in its burden remains unclear. This study aimed to provide accurate data on serological status of Cambodian children adolescents, evaluate vaccination timelin...

s of references provided in the position paper and GRADE tables  Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014 Oct 25; 384(9953):1521-1528. BACKGROUND: In October, 2012, a pertussis vaccination programme for pregnant women was introduced in response to an outbreak acro...

BACKGROUND AND OBJECTIVES Washington State experienced a pertussis epidemic from October 2011 to December 2012. There was wide variation in incidence by county. The objectives of this study were to determine how the pertussis epidemic affected infant vaccination in Washington State and whether the incidence in counties modified this effect. METHODS We conducted an ecologic before-after study ...

This review summarises the epidemiology and control of pertussis in England and Wales since the introduction of routine immunisation and considers the implications for future control. Routine infant immunisation with a whole-cell pertussis (wP) vaccine was introduced in 1957 and had a marked impact on the overall disease burden. Following a fall in vaccine coverage during the 1970s and 80s link...